Workflow
小区及居家养老服务
icon
Search documents
又一蓉企向港交所递交上市申请
Xin Lang Cai Jing· 2026-02-26 18:39
Group 1 - The core point of the article is that Jin Xin Kang Yang Industrial Group Co., Ltd. has submitted an application for listing on the Hong Kong Stock Exchange, marking another Chengdu enterprise's move towards capital market engagement [1][2] - Jin Xin Kang Yang is headquartered in Chengdu and is the second company from Jin Xin Group to enter the capital market, following Jin Xin Reproductive [1] - The main business of Jin Xin Kang Yang includes the operation of health and wellness communities and integrated medical and elderly care services, aiming to provide high-quality elderly care services [1] Group 2 - As of September 30, 2025, Jin Xin Kang Yang has established or acquired 23 integrated medical and elderly care facilities, enabling comprehensive medical and elderly care services [1] - The company ranks first in China's institutional elderly care service industry in terms of the proportion of elderly residents with mobility impairments and occupancy rates of integrated medical and elderly care facilities, with an 85% share [1] - In the Chengdu-Chongqing region, Jin Xin Kang Yang leads in the number of integrated medical and elderly care facilities and beds among professional private chain enterprises [1][2] Group 3 - Chengdu is actively promoting enterprises to connect with capital markets, exemplified by Jin Xin Kang Yang's listing application [2] - The Chengdu Financial Office plans to implement the "Rong Yi Shang" full lifecycle service for enterprise listings, leveraging various local financial resources and initiatives to accelerate the listing of quality enterprises domestically and internationally [2]
锦欣康养递表港交所 专注于向高龄长者及有更迫切养老需求的老年人提供医养结合服务
Zhi Tong Cai Jing· 2026-02-25 23:24
Company Overview - Jinxin Healthcare Industry Group Limited has submitted a listing application to the Hong Kong Stock Exchange, with China International Capital Corporation and GF Securities as joint sponsors [1] - The company is a leader in China's rapidly growing institutional elderly care service market, focusing on providing integrated medical and elderly care services to seniors aged 80 and above and those with urgent care needs [1] Market Position - As of September 30, 2025, Jinxin Healthcare ranks first among all major players in China's institutional elderly care service industry, with an 85% market share in both the proportion of elderly residents with mobility impairments and the occupancy rate of integrated medical and elderly care facilities [3] - The company also ranks first among private chain elderly care enterprises in China in terms of the number of integrated medical and elderly care facilities and beds in the Sichuan-Chongqing region [3] - Jinxin Healthcare has established or acquired 23 integrated medical and elderly care facilities, covering the Sichuan-Chongqing region, Yangtze River Delta, and Greater Bay Area [3] Services Offered - The company provides a comprehensive range of elderly care services, including housing, professional nursing and care services, nutritional management, social and cultural entertainment services, medical services, rehabilitation and assistance services, and on-demand services [4] Financial Performance - For the fiscal year ending December 31, 2023, the company reported revenues of approximately RMB 488.5 million, with a gross profit of RMB 106.0 million and a net profit of RMB 27.1 million [6][8] - Revenue is projected to increase to RMB 604.8 million in 2024 and RMB 547.0 million for the nine months ending September 30, 2025 [7] - The gross profit margin for 2023, 2024, and the nine months ending September 30, 2025, is reported at 21.7%, 23.3%, and 22.5%, respectively [10] Industry Overview - The elderly care industry in China is driven by significant demographic changes, with the population aged 65 and above growing at a compound annual growth rate (CAGR) of 3.9% from 2020 to 2024, and the population aged 80 and above growing at a CAGR of 5.1% [11] - The market size of the elderly care industry in China is expected to grow from RMB 7.4 trillion in 2020 to RMB 14.1 trillion in 2024, representing a CAGR of 17.5% [16]